Skip to main content

Transferrin

Transferrin is a liver-synthesized iron-transport protein with a half-life of about 7–8 days. Each molecule binds two ferric ions. Serum concentration depends on iron status, inflammation, hepatic function and protein losses, so transferrin is not a stand-alone test of nutritional status.[1][2][3]

Iron Studies​

  • Total iron-binding capacity (TIBC) relates to transferrin concentration. It often rises in iron deficiency and falls with inflammation or impaired hepatic synthesis.
  • Transferrin saturation (TSAT) is serum iron divided by TIBC, multiplied by 100, using compatible units.
  • TSAT is interpreted with ferritin, CBC, the clinical context and the laboratory method. Iron overload and iron deficiency use different thresholds, and a single normal range does not answer every clinical question.[3][4]

Iron deficiency may raise transferrin while concurrent inflammation lowers it, so a normal concentration does not exclude deficiency. A low TIBC can also make calculated TSAT appear relatively high despite reduced circulating iron.[3][5]

Preoperative Anemia​

ICCAMS recommends investigating the cause of anemia before surgery. Its iron-deficiency criteria include ferritin < 30 ng/mL and/or TSAT < 20%; with inflammation, ferritin < 100 ng/mL may indicate deficiency.[6] These criteria define iron deficiency. They are not an instruction to give IV iron to every patient with a low TSAT. ICCAMS states that IV iron is preferable to oral iron in preoperative iron-deficiency anemia; the time available before surgery affects route choice, and iron therapy is started as early as possible, ideally at least 3 weeks before surgery, although a shorter interval does not preclude treatment. Iron allergy contraindicates therapy, and sepsis is controlled before iron is started.[6] A 2025 meta-analysis of 12 randomized trials (930 elective-surgery patients) found higher post-treatment hemoglobin levels with IV iron (mean difference 0.77 g/dL, 95% CI 0.30–1.23) but did not detect a significant difference in transfusion rates or volumes versus oral iron.[13]

The Iron & Ferritin and Preoperative Labs pages cover the wider workup. Dialysis, heart failure and other inflammatory diseases have their own iron-treatment frameworks.

Soluble Transferrin Receptor​

Soluble transferrin receptor (sTfR), sometimes combined with log ferritin as the sTfR/log ferritin index, can help when routine tests leave iron deficiency uncertain in an inflammatory setting. A prospective multicenter study supported its added value in separating iron-deficiency anemia from anemia of chronic disease.[7] Assay availability, method-specific cutoffs and altered erythropoiesis limit interchangeability. sTfR is an adjunct to ferritin and TSAT, not a replacement.[3][6]

Why It Is Not a Nutritional Marker​

Like albumin and prealbumin, transferrin is a negative acute-phase protein. Iron deficiency can raise its concentration while inflammation or hepatic disease lowers it, obscuring nutritional interpretation.[2]

Historical studies illustrate this limitation:

  • Ingenbleek 1975: transferrin had intermediate sensitivity for malnutrition, lower than the prealbumin/retinol-binding protein complex. Iron deficiency raises transferrin synthesis and protein deficiency lowers it, which partly invalidates it as an index of protein depletion alone.[11]
  • Roza 1984: correlation with body cell mass at the group level did not produce reliable individual classification; reported false-positive and false-negative rates were 60% and 31%. Transferrin did not change significantly after two weeks of parenteral nutrition in the treated subgroup.[8]
  • Morlese 1997: kinetic measurements in 14 children with severe protein-energy malnutrition showed only fair correlations with wasting indices. This is pediatric mechanistic evidence and not an adult operative decision rule.[9]

Nutrition is screened and assessed with weight and intake history, examination and an accepted clinical framework. Nutrition support is not titrated to transferrin concentration.[2]

Liver Disease and Dialysis​

A mechanistic study of 40 liver specimens from patients with advanced liver disease linked hepatic transferrin expression with HNF4α activity. In 23 patients with paired serum and liver samples, serum transferrin correlated with hepatic transferrin mRNA expression (r = 0.51, p = 0.01).[10] In a kinetic study of 11 alcoholic patients, transferrin synthesis was lower in the 5 with cirrhosis than in 6 controls (0.9 vs 1.8 mg/kg/h), and higher in the 6 with fatty liver.[12]

In a 59-patient hemodialysis cohort, mean TIBC was 276, 217 and 176 mg/dL in well, moderately and poorly nourished patients by SGA (p < 0.00001). The authors noted that a lower TIBC in poorly nourished patients can falsely raise calculated TSAT and mask iron deficiency.[5] Iron indices are read together, and TIBC alone does not diagnose nutritional status or guide iron prescribing.

Comparison with Other Visceral Proteins​

FeatureAlbuminPrealbuminTransferrin
Approximate half-life20 days2 days7–8 days
Negative acute-phase responseYesYesYes
Measures nutritional intake or muscle stores reliablyNoNoNo
Important confoundingDistribution, dilution, synthesis and lossesInflammation and renal / hepatic diseaseIron status, inflammation, hepatic synthesis and losses
Clinical useRisk assessment in contextSelected prognostic information; no routine nutrition-monitoring targetIron-status assessment as part of a panel

Laboratory-specific reference intervals apply. A short half-life does not make a visceral protein a better therapeutic target.[2][3]

Reconstructive Relevance​

Transferrin is rarely the right marker for a nutritional decision in reconstructive urology or urogynecology. Its use is in the preoperative iron-status workup.

  • Major reconstruction with expected blood loss (cystectomy with diversion, complex prolapse repair, phalloplasty) warrants preoperative anemia screening and evaluation of an abnormal result. Iron deficiency is identified with ferritin and TSAT using the ICCAMS criteria above, and ICCAMS prefers IV to oral iron for preoperative iron-deficiency anemia.[6]
  • Cancer survivors and chronic inflammatory disease can have anemia of chronic disease with superimposed iron deficiency. The sTfR/log ferritin index can help when ferritin and TSAT are equivocal.[7]
  • Hemodialysis patients undergoing reconstruction need ferritin as well as TSAT, because low TIBC can falsely normalize TSAT.[5]
  • Cirrhosis lowers transferrin, and the value may add prognostic information about hepatic synthetic function. Its incremental value over albumin and INR is not established.[10][12]
  • Malnutrition is first screened for with a tool such as NRS-2002; SGA or a GLIM-based assessment can establish the diagnosis. Transferrin does not replace the clinical assessment.[2][14]

See Also​

References​

1. Kawabata H. "Transferrin and Transferrin Receptors Update." Free Radical Biology & Medicine. 2019;133:46–54. doi:10.1016/j.freeradbiomed.2018.06.037

2. Evans DC, Corkins MR, Malone A, et al. "The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper." Nutrition in Clinical Practice. 2021;36(1):22–28. doi:10.1002/ncp.10588

3. Szőke D, Panteghini M. "Diagnostic Value of Transferrin." Clinica Chimica Acta. 2012;413(15–16):1184–1189. doi:10.1016/j.cca.2012.04.021

4. Kasvosve I, Delanghe J. "Total Iron Binding Capacity and Transferrin Concentration in the Assessment of Iron Status." Clinical Chemistry and Laboratory Medicine. 2002;40(10):1014–1018. doi:10.1515/CCLM.2002.176

5. Kalantar-Zadeh K, Kleiner M, Dunne E, et al. "Total Iron-Binding Capacity-Estimated Transferrin Correlates With the Nutritional Subjective Global Assessment in Hemodialysis Patients." American Journal of Kidney Diseases. 1998;31(2):263–272. doi:10.1053/ajkd.1998.v31.pm9469497

6. Shander A, Corwin HL, Meier J, et al. Recommendations From the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS). Ann Surg. 2023;277(4):581–590. doi:10.1097/SLA.0000000000005721.

7. Skikne BS, Punnonen K, Caldron PH, et al. "Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index." American Journal of Hematology. 2011;86(11):923–927. doi:10.1002/ajh.22108

8. Roza AM, Tuitt D, Shizgal HM. "Transferrin — a Poor Measure of Nutritional Status." JPEN. Journal of Parenteral and Enteral Nutrition. 1984;8(5):523–528. doi:10.1177/0148607184008005523

9. Morlese JF, Forrester T, Del Rosario M, Frazer M, Jahoor F. "Transferrin Kinetics Are Altered in Children With Severe Protein-Energy Malnutrition." The Journal of Nutrition. 1997;127(8):1469–1474. doi:10.1093/jn/127.8.1469

10. Guldiken N, Argemi J, Gurbuz B, et al. "Serum Transferrin as a Biomarker of Hepatocyte Nuclear Factor 4 Alpha Activity and Hepatocyte Function in Liver Diseases." BMC Medicine. 2021;19(1):39. doi:10.1186/s12916-021-01917-6

11. Ingenbleek Y, Van Den Schrieck HG, De Nayer P, De Visscher M. "Albumin, Transferrin and the Thyroxine-Binding Prealbumin/Retinol-Binding Protein (TBPA-RBP) Complex in Assessment of Malnutrition." Clinica Chimica Acta. 1975;63(1):61–67. doi:10.1016/0009-8981(75)90379-4

12. Potter BJ, Chapman RW, Nunes RM, Sorrentino D, Sherlock S. "Transferrin Metabolism in Alcoholic Liver Disease." Hepatology. 1985;5(5):714–721. doi:10.1002/hep.1840050503

13. Yue L, Zhang J, Li C, et al. "Preoperative intravenous versus oral iron supplementation for elective surgery: evidence based on 12 randomized trials." Postgrad Med. 2025;137(2):155–163. doi:10.1080/00325481.2025.2454218

14. Jensen GL, Cederholm T, Correia MITD, et al. "GLIM consensus approach to diagnosis of malnutrition: A 5-year update." JPEN J Parenter Enteral Nutr. 2025;49(4):414–427. doi:10.1002/jpen.2756